ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses.

Nature Immunology
Stamatia PapoutsopoulouSteven C Ley

Abstract

The TPL-2 MEK kinase is essential for activation of the Erk MAP kinase pathway during innate immune responses. TPL-2 is found in complex with ABIN-2 (A20-binding inhibitor of NF-kappaB 2). Here, using antigen-presenting cells from ABIN-2-deficient mice, we show that ABIN-2 was required for optimal activation of Erk induced by receptors that signal via TPL-2, including Toll-like receptor 4 and tumor necrosis factor receptor 1 in macrophages, and CD40 in B cells. ABIN-2 was necessary for the maintenance of TPL-2 protein stability. In contrast, ABIN-2 deficiency did not affect agonist-induced regulation of transcription factor NF-kappaB. Stimulation of ABIN-2-deficient macrophages via Toll-like receptor 4 showed that different thresholds of Erk signaling were required for optimal induction of tumor necrosis factor and interleukin 1beta. Thus, ABIN-2 acts to positively regulate the Erk signaling potential by stabilizing TPL-2.

References

Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C PatriotisP N Tsichlis
Mar 1, 1995·Molecular and Cellular Biology·I AlkalayY Ben-Neriah
Jan 1, 1994·Annual Review of Immunology·P A Baeuerle, T Henkel
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·S O'GormanY Marchuk
Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Jun 8, 2001·The Journal of Biological Chemistry·S Van HuffelR Beyaert
Apr 27, 2002·The Journal of Biological Chemistry·Soren BeinkeSteven C Ley
Sep 18, 2002·The EMBO Journal·Aristides G EliopoulosPhilip N Tsichlis
Oct 3, 2002·Nature Reviews. Immunology·Qiutang Li, Inder M Verma
Dec 17, 2002·Molecular and Cellular Biology·Valerie LangSteven C Ley
Jan 14, 2003·Annual Review of Immunology·Kiyoshi TakedaShizuo Akira
Feb 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patricia J JorritsmaKim Bottomly
Mar 26, 2003·Cell Death and Differentiation·H WajantP Scheurich
Jul 2, 2003·Molecular and Cellular Biology·S BeinkeS C Ley
Jul 26, 2003·The EMBO Journal·Aristides G EliopoulosPhilip N Tsichlis
Jan 27, 2004·Nature Cell Biology·Tewis BouwmeesterGiulio Superti-Furga
May 4, 2004·Nature Reviews. Molecular Cell Biology·Lin-Feng Chen, Warner C Greene
Jun 16, 2004·Current Opinion in Cell Biology·Lijun Sun, Zhijian J Chen
Jun 25, 2004·The Biochemical Journal·Sören Beinke, Steven C Ley
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Sep 17, 2004·The Journal of Clinical Investigation·Kenji SugimotoTetsuya Matsuguchi
Sep 28, 2005·Nature Immunology·Shintaro SatoShizuo Akira

❮ Previous
Next ❯

Citations

Dec 4, 2010·Immunologic Research·Xiao-Ping ZhongHongjie Pan
Mar 14, 2009·Chemical Reviews·Yu-Hsin ChiuZhijian J Chen
Jan 24, 2013·Mucosal Immunology·M Hedl, C Abraham
Dec 9, 2008·Nature Immunology·Srividya SriskantharajahSteven C Ley
Jul 21, 2011·Nature Immunology·Andrea OeckinghausSankar Ghosh
Aug 31, 2013·Nature Reviews. Molecular Cell Biology·Kristopher ClarkPhilip Cohen
Jul 20, 2007·Immunology and Cell Biology·Ashish Banerjee, Steve Gerondakis
Dec 14, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yogesh DwivediGhanshyam N Pandey
Jun 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ana RiscoAna Cuenda
Nov 15, 2008·The Journal of Biological Chemistry·Beatrice CoornaertRudi Beyaert
Aug 12, 2009·The Journal of Experimental Medicine·Frank KaiserAnne O'Garra
Sep 24, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Xiaomin DengStephen B Pruett
May 9, 2007·Molecular and Cellular Biology·Brian K WeaverRobert D Schreiber
Jun 27, 2012·Molecular and Cellular Biology·Huei-Ting YangSteven C Ley
Dec 17, 2011·Journal of Applied Physiology·Ping TaishiJames M Krueger
Jun 7, 2011·Arthritis Research & Therapy·Geert van Loo, Rudi Beyaert
Dec 31, 2011·Haematologica·Yingwen BiMing-Qing Du
Apr 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Shaochun YuanAnlong Xu
Jun 10, 2014·Proceedings of the National Academy of Sciences of the United States of America·Abduelhakem Ben-AddiSteven C Ley
Feb 28, 2015·International Journal of Molecular Sciences·Hye Won LeeDo-Hyun Nam
Nov 29, 2011·Cytokine & Growth Factor Reviews·Kelly VerhelstRudi Beyaert
Mar 8, 2011·Cancer Letters·Maria VougioukalakiAristides G Eliopoulos
Jul 6, 2010·Biochemical Pharmacology·Lynn VerstrepenRudi Beyaert
May 26, 2009·Biochemical Pharmacology·Lynn VerstrepenRudi Beyaert
Mar 23, 2012·Immunological Reviews·Edward W Harhaj, Vishva M Dixit
Aug 24, 2010·Immunological Reviews·John P GrahamGail A Bishop
Feb 6, 2007·Seminars in Immunology·Taro Kawai, Shizuo Akira
May 12, 2010·Biochemical and Biophysical Research Communications·Amde Selassie Shifera
Apr 20, 2017·Science Signaling·Kate SengerAli A Zarrin
Oct 20, 2018·The Journal of Experimental Medicine·Sonia VenturaSteven C Ley
Oct 26, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sambit K NandaPhilip Cohen
Mar 23, 2012·Immunological Reviews·Thorsten GantkeSteven C Ley
Apr 27, 2012·Physiological Reviews·John M Kyriakis, Joseph Avruch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.